Depression & Anxiety
Author Guidelines
1. SUBMISSION
Authors should kindly note that submission of a paper will be held to imply that it is unpublished work which is not being considered for publication elsewhere. If accepted, it is expected that the paper will not be published in another journal or book in either the same or another format or language.
Once the submission has been prepared in accordance with the Author Guidelines, manuscripts should be submitted online via ScholarOne at mc.manuscriptcentral.com/da. Click here for more details on how to use ScholarOne.
The submission system will prompt the author to use an ORCID iD (a unique author identifier) to help distinguish their work from that of other researchers. Click here to find out more.
By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices.wiley.com/statements/data-protection-policy.html.
For help with submissions, authors should contact the Editorial Office: dajrnl@wiley.com.
Preprints
Depression and Anxiety will consider submissions that have previously been made available online, either on a preprint server like arXiv, bioRxiv, or PeerJ PrePrints, or on the authors’ own website. However, any such submissions must not have been published in a scientific journal, book or other venue that could be considered formal publication. Authors must inform the editorial office at submission if their paper has been made available as a preprint.
Authors of accepted papers that were made available as preprints must be able to assign copyright to Depression and Anxiety, or agree to the terms of the Wiley Open Access agreement and pay the associated fee.
Given that the measurable impact of the article is diminished when citations are split between the preprint and the published article, authors are required to:
Update the entry on the preprint server so that it links to and cites the DOI for the published version
Cite only the published article themselves
Return to the Table of Contents
2. AIMS AND SCOPE
Depression and Anxiety, the official journal of the Anxiety and Depression Association of America (ADAA), welcomes original research and synthetic review articles covering neurobiology (genetics and neuroimaging), epidemiology, experimental psychopathology, and treatment (psychotherapeutic and pharmacologic) aspects of mood and anxiety disorders and related phenomena in humans. The journal publishes only two types of articles: original Research Papers and Reviews. A priority is placed on treatment and review papers, and on papers with information and findings that will enhance the clinical evaluation and care of individuals struggling with the effects of these disorders.
Return to the Table of Contents
3. MANUSCRIPT CATEGORIES AND REQUIREMENTS
Depression and Anxiety publishes the following contribution types:
Research Articles
Review/Theoretical Articles
Research Articles
Research articles must be 3500 words or fewer, exclusive of tables, figures, and references, and include Introduction, Materials and Methods, Results, Discussion, and Conclusion sections conforming to standard scientific reporting style. The introduction should include a succinct summary of the known literature in the area and a rationale for and justification of the purpose of the study and why the experimental question and hypothesis are important or novel. Whenever possible, information on why the study is important for the practicing clinician should be provided. Detailed information on statistics should be provided such as name of statistical test, whether tests were one- or two-tailed, test used for each set of data, and correction factors, if any, for multiple comparisons. Data and figures should present or reflect standard deviations rather than standard error of means. All significant and relevant non-significant results must include test values, degree(s) of freedom, and probability. Aclear exposition of the clinical and scientific importance of the study.should be included Articles should strive to highlight the clinical meaning of the constructs and results as opposed to their methodological and mechanistic implications.
Review/Theoretical Articles
Review and theoretical articles are usually invited, but submitted reviews or theory-oriented articles will be considered. Review or Theoretical Articles must be a maximum of 4500 words, exclusive of tables, figures and references. An abstract is required but need not be organized into four sections (i.e., Background, Methods, Results, Conclusions). The text should flow smoothly, and subdivisions (e.g. Introduction, Methods, Results) within the manuscript are not necessary. Proposals for papers of this nature should be directed to the appropriate Editor-in-Chief, who will consult with the author before manuscript submission. The scientific rationale for, and clinical importance of, the review should be clearly articulated.
Return to the Table of Contents
4. PREPARING THE SUBMISSION
Cover Letters
Cover letters are not mandatory; however, they may be supplied at the author's discretion.
Parts of the Manuscript
The manuscript should be submitted in separate files: main text file; figures.
Main Text File
The text file should be presented in the following order:
A short informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
A short running title of less than 40 characters;
The full names of the authors;
The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
Acknowledgments;
Abstract and keywords;
Main text;
References;
Tables (each table complete with title and footnotes);
Figure legends;
Appendices (if relevant)
Figures and supporting information should be supplied as separate files.
Authorship
Please refer to Depression and Anxiety’s Authorship policy in the Editorial Policies and Ethical Considerations section for details on author listing eligibility.
Acknowledgements
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.
Conflict of Interest Statement
Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the ‘Conflict of Interest’ section in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.
Abstract
The abstract should not exceed 200 words unless absolutely necessary, and should under no circumstances exceed 250 words. The abstract should appear as a single paragraph, which should enable readers to quickly comprehend the thrust of the article prior to reading the article itself. Abbreviations should be avoided. They should conform to the following structure, using the following as subheadings: Background, Methods, Results, Conclusions. Reference citations within the abstract are not permitted. Please provide main keywords.
Keywords
Please provide up to 7 keywords. Keywords should be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh.
Main Text
Depression and Anxiety uses British/US spelling; however, authors may submit using either option, as spelling of accepted papers is converted during the production process.
Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.
References
References should be prepared according to the Publication Manual of the American Psychological Association. This means in text citations should follow the author-date method whereby the author's last name and the year of publication for the source should appear in the text, for example, (Jones, 1998). The complete reference list should appear alphabetically by name at the end of the paper.
For more information about APA referencing style, please refer to Wiley's Manuscript Preparation Guidelines.
Endnotes
Endnotes should be placed as a list at the end of the paper only, not at the foot of each page. They should be numbered in the list and referred to in the text with consecutive, superscript Arabic numerals. Keep endnotes brief; they should contain only short comments tangential to the main argument of the paper.
Footnotes
Footnotes should be placed as a list at the end of the paper only, not at the foot of each page. They should be numbered in the list and referred to in the text with consecutive, superscript Arabic numerals. Keep footnotes brief; they should contain only short comments tangential to the main argument of the paper and should not include references.
Figure Legends
Legends should be concise but comprehensive—the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement.
Tables
Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.
Figures
Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted. Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.
Color Figures
Figures submitted in color may be reproduced in color online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.
Supporting Information
Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.
Click here for Wiley’s FAQs on supporting information.
Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.
General Style Points
The following points provide general advice on formatting and style.
Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation only.
Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
Numbers: Numbers under 10 are spelt out, except for: measurements with a unit (8mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils).
Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.
Resource Identification Initiative
Depression and Anxiety supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.
Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.
Additionally, authors must include the RIIDs in the list of keywords associated with the manuscript.
To Obtain Research Resource Identifiers (RRIDs):
Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
Search for the research resource (please see the section titled “Search Features and Tips” for more information).
Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text.
If there is a resource that is not found within the Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.
If any difficulties in obtaining identifiers arise, please contact mrii-help@scicrunch.org for assistance.
Example Citations:
Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"
Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"
Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)"
Tools, Software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID:nif-0000-00280)"
Article Preparation Support
Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence. Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.
5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS
Peer Review and Acceptance
The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Except where otherwise stated, manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements.
Wiley's policy on the confidentiality of the review process is available here.
Human Studies and Subjects
For manuscripts reporting medical studies that involve human participants, a statement identifying the ethics committee that approved the study and confirmation that the study conforms to recognized standards is required, for example: Declaration of Helsinki; US Federal Policy for the Protection of Human Subjects; or European Medicines Agency Guidelines for Good Clinical Practice. It should also state clearly in the text that all persons gave their informed consent prior to their inclusion in the study.
Patient anonymity should be preserved. Photographs need to be cropped sufficiently to prevent human subjects being recognized (or an eye bar should be used). Images and information from individual participants will only be published where the authors have obtained the individual's free prior informed consent. Authors do not need to provide a copy of the consent form to the publisher; however, in signing the author license to publish, authors are required to confirm that consent has been obtained. Wiley has a standard patient consent form available for use.
Animal Studies
A statement indicating that the protocol and procedures employed were ethically reviewed and approved, as well as the name of the body giving approval, must be included in the Methods section of the manuscript. Authors are encouraged to adhere to animal research reporting standards, for example the ARRIVE guidelines for reporting study design and statistical analysis; experimental procedures; experimental animals and housing and husbandry. Authors should also state whether experiments were performed in accordance with relevant institutional and national guidelines for the care and use of laboratory animals:
US authors should cite compliance with the US National Research Council's Guide for the Care and Use of Laboratory Animals, the US Public Health Service's Policy on Humane Care and Use of Laboratory Animals, and Guide for the Care and Use of Laboratory Animals.
UK authors should conform to UK legislation under the Animals (Scientific Procedures) Act 1986 Amendment Regulations (SI 2012/3039).
European authors outside the UK should conform to Directive 2010/63/EU.
Clinical Trial Registration
Depression and Anxiety requires that clinical trials are prospectively registered in a publicly accessible database and clinical trial registration numbers should be included in all papers that report their results. Authors are asked to include the name of the trial register and the clinical trial registration number at the end of the abstract. If the trial is not registered, or was registered retrospectively, the reasons for this should be explained.
Research Reporting Guidelines
Accurate and complete reporting enables readers to fully appraise research, replicate it, and use it. Authors are encouraged to adhere to recognized research reporting standards. The EQUATOR Network collects more than 370 reporting guidelines for many study types, including for:
Randomised trials: CONSORT
Observational studies: STROBE
Systematic reviews: PRISMA
Case reports: CARE
Qualitative research: SRQR
Diagnostic / prognostic studies: STARD
Quality improvement studies: SQUIRE
Economic evaluations: CHEERS
Animal pre-clinical studies: ARRIVE
Study protocols: SPIRIT
Clinical practice guidelines: AGREE
We also encourage authors to refer to and follow guidelines from:
Future of Research Communications and e-Scholarship (FORCE11)
National Research Council's Institute for Laboratory Animal Research guidelines
The Gold Standard Publication Checklist from Hooijmans and colleagues
Minimum Information Guidelines from Diverse Bioscience Communities (MIBBI) website
FAIRsharing website
Species Names
Upon its first use in the title, abstract and text, the common name of a species should be followed by the scientific name (genus, species and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, the scientific name should be used only.
Genetic Nomenclature
Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; examples of acceptable nomenclature are provided here: varnomen.hgvs.org.
Sequence Data
Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number #####’. Addresses are as follows:
DNA Data Bank of Japan (DDBJ): www.ddbj.nig.ac.jp
EMBL Nucleotide Archive: www.ebi.ac.uk/ena
GenBank: www.ncbi.nlm.nih.gov/genbank
Proteins sequence data should be submitted to either of the following repositories:
Protein Information Resource (PIR): pir.georgetown.edu
SWISS-PROT: www.expasy.ch/sprot/sprot-top
Conflict of Interest
Depression and Anxiety requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.
Funding
Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/
Authorship
The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:
Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and
Been involved in drafting the manuscript or revising it critically for important intellectual content; and
Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.
Joint first or senior authorship: In the case of joint first authorship a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’
Data Sharing and Data Accessibility
Please review Wiley’s policy here. Depression and Anxiety expects but does not require data sharing.
All accepted manuscripts are required to publish a data availability statement to confirm the presence or absence of shared data. Depression and Anxiety recognizes the many benefits of archiving research data. Depression and Anxiety expects you to archive all the data from which your published results are derived in a public repository. The repository that you choose should offer you guaranteed preservation (see the registry of research data repositories at https://www.re3data.org/) and should help you make it findable, accessible, interoperable, and re-useable, according to FAIR Data Principles.
Depression and Anxietyconfidential or proprietary information) but notes that the FAIR principles encourage you to share data in ways that are as open as possible (but that can be as closed as necessary). If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data. If you cannot share the data described in your manuscript, for example for legal or ethical reasons, or do not intend to share the data then you must provide the appropriate data availability statement. Sample statements are available here. If published, all statements will be placed in the heading of your manuscript.
Publication Ethics
Depression and Anxiety is a member of the Committee on Publication Ethics (COPE). Note Depression and Anxiety uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley’s Top 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.
ORCHID
As part of Depression and Anxiety’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.
Referrals to the Journal Brain and Behavior
This journal works together with Wiley’s Open Access Journal, Brain and Behavior, to enable rapid publication of good quality research that is unable to be accepted for publication by our journal. Authors will be offered the option of having the paper, along with any related peer reviews, automatically transferred for consideration by the Editor of Brain and Behavior. Authors will not need to reformat or rewrite their manuscript at this stage, and publication decisions will be made a short time after the transfer takes place. The Editor of Brain and Behavior will accept submissions that report well-conducted research which reaches the standard acceptable for publication. Accepted papers can be published rapidly: typically within 15 days of acceptance. Brain and Behavior is a Wiley Open Access journal and article publication fees apply. For more information please go to the Brain and Behavior journal.
6. AUTHOR LICENSING
If a paper is accepted for publication, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.
Authors may choose to publish under the terms of the journal’s standard copyright agreement, or OnlineOpen under the terms of a Creative Commons License.
General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under OnlineOpen, please click here. (Note that certain funders mandate a particular type of CC license be used; to check this please click here.)
Self-Archiving Definitions and Policies: Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions. Please click here for more detailed information about self-archiving definitions and policies.
Open Access fees: Authors who choose to publish using OnlineOpen will be charged a fee. A list of Article Publication Charges for Wiley journals is available here.
Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.
7. PUBLICATION PROCESS AFTER ACCEPTANCE
Accepted Article Received in Production
When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. They will be asked to sign a publication license at this point.
Accepted Articles
Depression and Anxiety offers Wiley’s Accepted Articles service for all manuscripts accepted for publication. This service ensures that accepted ‘in press’ manuscripts are published online very soon after acceptance, prior to copy-editing or typesetting. Accepted Articles are published online a few days after final acceptance, appear in PDF format only, are given a Digital Object Identifier (DOI), which allows them to be cited and tracked, and are indexed by PubMed. After publication of the final version article (the Version of Record), the DOI remains valid and can continue to be used to cite and access the article.
Accepted Articles are indexed by PubMed; submitting authors should therefore carefully check the names and affiliations of all authors provided in the cover page of the manuscript so it is correct for indexing. Subsequently the final copyedited and proofed articles will appear in an issue on Wiley Online Library; the link to the article in PubMed will automatically be updated.
Proofs
Once the paper has been typeset, the author will receive an email notification of the URL from where to download the typeset page proofs of the article in PDF format; associated forms and full instructions on how to correct and return the file are also provided.
Authors are responsible for all statements made in their work, including changes made during the editorial process and thus the proofs must be checked carefully. Note that proofs should be returned within 48 hours from receipt.
Publication Charges
There are no mandatory charges to authors publishing in Depression and Anxiety.
Authors may choose to publish in an open access format through OnlineOpen, which carries a fee (see the section on Author Licensing).
Early View
Depression and Anxiety offers rapid publication via Wiley’s Early View service. Early View articles (first online Version of Record) are published on Wiley Online Library before inclusion in an issue of Depression and Anxiety. Note there may be a delay after corrections are received before the article appears online, as the proofs are carefully reviewed. Once the article is published in Early View, no further changes to the article are possible. The Early View article is fully citable using the Digital Object Identifier (DOI) and carries an online publication date.
Return to the Table of Contents
8. POST PUBLICATION
Access and Sharing
When an article is published online:
The author will receive an email alert (if requested).
Authors can share a link to their published article through social media.
The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
For non-open access articles, the corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.
Article Promotion Support
Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.
Measuring the Impact of an Article
Wiley helps authors to measure the impact of their research through specialist partnerships with Kudos and Altmetric.
Return to the Table of Contents
9. CONTACT DETAILS
A complete list of contacts for Depression and Anxiety is available on the journal’s Contacts page.
Author Guidelines updated February 21, 2019
Return to the Table of Contents
